Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target.
about
A research agenda for helminth diseases of humans: intervention for control and eliminationSchistosomiasis vaccinesNovel therapeutic and prevention approaches for schistosomiasis: reviewSchistosomiasis vaccines: where do we stand?A transcriptomic analysis of Echinococcus granulosus larval stages: implications for parasite biology and host adaptationExploring molecular variation in Schistosoma japonicum in ChinaEchinococcus P29 antigen: molecular characterization and implication on post-surgery follow-up of CE patients infected with different species of the Echinococcus granulosus complex.Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene.Identification and characterization of six novel tetraspanins from Schistosoma japonicumIt's All about Those Bases: The Need for Incorporating Parasite Genetic Heterogeneity into the Development of Schistosome VaccinesMolecular insights into a tetraspanin in the hydatid tapeworm Echinococcus granulosusHaving a pair: the key to immune evasion for the diploid pathogen Schistosoma japonicumGenetic diversity and selection of three nuclear genes in Schistosoma japonicum populationsA next-generation microarray further reveals stage-enriched gene expression pattern in the blood fluke Schistosoma japonicum.Vaccination against helminth parasite infections.Accelerated evolution of schistosome genes coding for proteins located at the host-parasite interface.Schistosoma tegument proteins in vaccine and diagnosis development: an updateQuantitative multiplexed proteomics of Taenia solium cysts obtained from the skeletal muscle and central nervous system of pigs.Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.
P2860
Q21562256-CD71FC54-6FC3-4B4A-B19F-44C0D4773E00Q24598949-C018CD86-6622-4E57-B2CA-4A968EDBDF18Q27008897-4F76B18F-E115-4191-B515-4052A11B956EQ28066042-3B82F3E3-0DE3-48B3-BE88-8565955B4B73Q28485374-EE1A4081-C498-497D-9BED-28789269C9E5Q28606875-88805084-2D2C-4155-A5FA-A1A709913241Q33650344-4756B85C-6C4D-4A1A-8C85-FEB293821B69Q35281233-4736E4C9-29EB-460D-B77E-B5CF1A3B3AB6Q35471911-AE67F801-4DD0-478F-A451-85BEF7446E10Q35667056-D11B796B-A764-46B0-BDF3-D35047401EB8Q35731900-8AD73669-781B-403F-B436-1F16FFC4FA99Q35861537-6B39F514-6D9D-4A7C-84BC-A9F96F3965C0Q36284503-65ADAA6B-02C6-457F-9787-ACB4BD4D0DF7Q37576422-A30BF3CD-88CA-42EA-A544-53AF30F4DE72Q38194247-4432DF16-E53D-4063-83A5-15FCDAB336E1Q41557454-5C4EE04B-6E51-4217-941A-B84A9B30DA5DQ41643982-22CE5BF4-4710-4274-A7D5-01DDCA4B3B7AQ42704010-5625D1E3-FA79-47FD-ACC5-A48725D603D7Q43088896-B08E0468-D450-4D32-84F9-131895985992
P2860
Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inconsistent protective effica ...... aspanin-2 as a vaccine target.
@ast
Inconsistent protective effica ...... aspanin-2 as a vaccine target.
@en
type
label
Inconsistent protective effica ...... aspanin-2 as a vaccine target.
@ast
Inconsistent protective effica ...... aspanin-2 as a vaccine target.
@en
prefLabel
Inconsistent protective effica ...... aspanin-2 as a vaccine target.
@ast
Inconsistent protective effica ...... aspanin-2 as a vaccine target.
@en
P2093
P2860
P1476
Inconsistent protective effica ...... aspanin-2 as a vaccine target.
@en
P2093
David Blair
Jianfeng Zhang
Ling Kuang
Wenbao Zhang
Yuesheng Li
P2860
P356
10.1371/JOURNAL.PNTD.0001166
P407
P577
2011-05-31T00:00:00Z